Watch our capabilities presentation to learn how our integrated CDMO solutions accelerate immune cell therapy development from early-phase to commercial readiness.
Serial entrepreneur has created, built and sold three CDMOs GAINESVILLE, Fla. – May 21, 2024 – Kincell Bio, LLC (“Kincell”), a technology-forward contract development and...
Read MoreKincell Bio has acquired a state-of-the-art manufacturing facility in North Carolina, expanding our network to include late-phase and pivotal capabilities.
eXmoor pharma, the full-service cell and gene therapy (CGT) manufacturing partner, and Kincell Bio, a contract development and manufacturing organization (CDMO) focused on cell therapies,...
Read MoreA small CDMO called Kincell Bio launched Wednesday, with its CEO hoping to fill a niche offering cell therapy manufacturing for early-stage biotech startups.
Kincell Bio, a technology-forward contract development and manufacturing organization (CDMO) focused on cell therapies, today emerged from stealth with $36 million in new funding. Kineticos...
Read More
1622 NW 55th Place
Gainesville, FL 32653
20 TW Alexander Dr, Suite 130
RTP, NC 27713
